| Oct 30 |
Viking Therapeutics CFO Cashes Out: $10M in Shares Sold Amidst Stock Surge
|
| Oct 29 |
Pfizer Unveils Its Next Black Box In Obesity. It's Taking On Amgen.
|
| Oct 28 |
Viking Therapeutics: Lots Of Positives
|
| Oct 28 |
Viking Therapeutics to Highlight Clinical Data from VK2735 Obesity Program in Presentations at ObesityWeek® 2024
|
| Oct 27 |
Could Buying This Weight Loss Stock Be Like Investing in Novo Nordisk At The Dawn of The GLP-1 Revolution?
|
| Oct 25 |
Viking Therapeutics: Q3 Earnings Report Loads A Barrage Of Catalysts
|
| Oct 24 |
Why Viking Therapeutics Stock Soared by Nearly 21% on Thursday
|
| Oct 24 |
Viking Therapeutics stock soars on heels of Q3 beat
|
| Oct 24 |
Viking Therapeutics Skyrockets After Dealing A Blow To Eli Lilly's Obesity Triplet
|
| Oct 24 |
Viking Therapeutics Soars 21%: Is This Obesity Drug the Next Blockbuster Weight Loss Treatment?
|
